Cargando…
Expedited approval of cancer drugs without randomized controlled trials: Too good to be true?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089560/ https://www.ncbi.nlm.nih.gov/pubmed/30123417 http://dx.doi.org/10.18632/oncotarget.25799 |
| _version_ | 1783347042862497792 |
|---|---|
| author | Shepshelovich, Daniel Amir, Eitan |
| author_facet | Shepshelovich, Daniel Amir, Eitan |
| author_sort | Shepshelovich, Daniel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6089560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-60895602018-08-17 Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? Shepshelovich, Daniel Amir, Eitan Oncotarget Editorial Impact Journals LLC 2018-07-24 /pmc/articles/PMC6089560/ /pubmed/30123417 http://dx.doi.org/10.18632/oncotarget.25799 Text en Copyright: © 2018 Shepshelovich et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Shepshelovich, Daniel Amir, Eitan Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title | Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title_full | Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title_fullStr | Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title_full_unstemmed | Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title_short | Expedited approval of cancer drugs without randomized controlled trials: Too good to be true? |
| title_sort | expedited approval of cancer drugs without randomized controlled trials: too good to be true? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089560/ https://www.ncbi.nlm.nih.gov/pubmed/30123417 http://dx.doi.org/10.18632/oncotarget.25799 |
| work_keys_str_mv | AT shepshelovichdaniel expeditedapprovalofcancerdrugswithoutrandomizedcontrolledtrialstoogoodtobetrue AT amireitan expeditedapprovalofcancerdrugswithoutrandomizedcontrolledtrialstoogoodtobetrue |